Authors


Emily Skotte, DNP, APRN, ACNP-BC

Latest:

Recognition of the Advanced Practice Preceptor Role in Oncology

A tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.


Elizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN®

Latest:

Elizabeth Loach on Integrating Frontline Staff in Nursing Task Forces

Elizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, discusses the importance of including frontline nurses in nursing leadership task forces.


Nicole Franklin, MS, RDN, CSO, LDN

Latest:

Dispelling Nutrition Myths for Patients With Cancer

Entering the words nutrition and cancer into Google returns as many as 718 million hits. With an overabundance of opinions, it can be challenging to separate fact from fiction.


Amber Thomassen, APRN-BC

Latest:

How I Counsel Patients About Lung Cancer Screening

A lung cancer screening navigator offers their perspective on shared decision-making.


Kiah Purcell, MSN, AGPCNP-BC

Latest:

Nurses, APPs Lead as Sub-Investigators in Oncology Clinical Trials

According to a nurse practitioner who works in myeloma research, nurses and APPs are responsible for much of the clinical work with patients involved in trials.


La-Urshalar Brock, MSN, CNM, FNP-BC

Latest:

Facilitating End-of-Life Care for Patients With Breast Cancer

Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.


Kate Kennedy, MSN, APRN, ACNPBC, AOCNP

Latest:

Determining the Cause of Bicytopenia in a Patient With Progressive Dyspnea

"Differential diagnoses in patients with bicytopenia—particularly those with preserved platelets—are broad and require careful physical examination."


Kelly L. Garvin, BSN, RN, OCN

Latest:

Expert Weighs in on Future of CAR T-Cell Therapy Treatment Directions

Kelly L. Garvin, BSN, RN, OCN, discusses what changes she hopes to see in CAR T-Cell therapy treatment over the coming years.


Benjamin Besse, MD, PhD

Latest:

Safety Management With Amivantamab Plus Lazertinib in NSCLC

Benjamin Besse, MD, PhD, shares AE management strategies with amivantamab/lazertinib in EGFR-positive NSCLC following CHRYSALIS-2 results.


Erin Pierce, MSN, APRN, FNP-C

Latest:

“Be Part of the Revolution”: APPs as Primary Investigators in Oncology

Nurse practitioners and physician assistants can advocate to play a number of roles in oncology research, including primary investigators.


Dylann Cohn-Emery

Latest:

Amphiphile Vaccine Extends RFS in KRAS+ Pancreatic Cancer

In a phase 1 study, ELI-002 2P improved relapse-free survival in pancreatic and colorectal cancer, with stronger benefit in patients with T-cell responses.


Megan Hollasch

Latest:

Darolutamide-ADT Combination Lengthens rPFS in mHSPC Regardless of Disease Volume

Patients with metastatic hormone-sensitive prostate cancer experienced increase rPFS and other efficacy end points with darolutamide plus ADT.


Nicole Gay, APRN-C

Latest:

How I Counsel Patients About Lung Cancer Screening

A lung cancer screening navigator offers their perspective on shared decision-making.


Kimberly Podsada, BSN, RN, MSN, NP-C, CNS

Latest:

Encouraging CDK4/6 Adherence Through Emotional Awareness

Kimberly Podsada, BSN, RN, MSN, NP-C, CNS, explained that understanding a patient’s emotional needs can help educate them on treatment adherence.


Kathryn Johnson, DNP, MSc, FNP-BC

Latest:

Clinical Trials Can Open Doors for Patients With Myeloproliferative Neoplasms

Clinical trials can provide patients with myeloproliferative neoplasms expanded treatment options.


Martha Bentley-McLachlan, BSN, RN, OCN, PMGT-BC

Latest:

Navigating Difficult Conversations in Cancer Pain Management

Difficult conversations in cancer pain management should include core values and principles, setting realistic expectations, and building the patient-client relationship from the very beginning.


Kimberly Halla, NP

Latest:

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.



Erika Hamilton, MD

Latest:

Safety Profiles to Look Out for in New Breast Cancer Treatments

New therapies in breast cancer, particularly ADCs, present unique safety profiles for nurses to be aware of, according to Erika Hamilton, MD.


Todd Kennedy

Latest:

Final Thoughts and Hope for a Cure

Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma while expressing optimism about emerging therapies like CAR T cells that offer deeper remissions and improved quality of life.


Benjamin Gerendash, MSN, RN, AGACNP-BC

Latest:

Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights

Experts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.


Tajuana Bradley, MS, FNP-BC

Latest:

Consistent Monitoring for ESR1 Mutations Essential in HR+, HER2- mBC

Patients with HR-positive, HER2-negative metastatic breast cancer should be consistently tested for ESR1 mutations to inform next lines of therapy.


Julian Adams, PhD

Latest:

Addressing Production and Logistic Challenges in Cell Therapy

“We've had to develop a unique process and a unique cryo buffer that allows us to freeze natural killer cells and recover greater than 90% of those cells. So, the new GDA-201 cryo-preserved is now going to be an off-the-shelf product and we're going to reinstitute a multicenter study in lymphoma to include both histologies of follicular lymphoma and diffuse large B cell lymphoma.”


David A. Braun, MD, PhD

Latest:

Nurses, APPs Critical to Getting Oncology Patients Newer Therapies

The role of nurses and APPs is crucial to ensuring patients with cancer can receive newer therapies, shares David A. Braun, MD, PhD.


Omar Nadeem, MD

Latest:

Referral Process With Bispecifics: Challenges and Support

Dr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.


Julia Manna, LMSW

Latest:

The Transformative Power of Self-Compassion, Gratitude, and Kindness in Cancer

The 3 fundamental coping mechanisms patients should have embedded into their care plan are self-compassion, gratitude, and kindness.


Daniel LaPook, MSW LMSW

Latest:

Creating Safe Spaces for LGBTQIA+ Patients With Cancer

Oncology nurses and APPs can help reduce discrimination faced by patients with cancer who are members of the LGBTQIA+ community.


Christina Monaco, LMSW

Latest:

Intro to AYA Patients, Survivors, and Substance Use

Adolescent and young adult survivors of cancer face increased substance use risks due to developmental delays, limited support, and coping mechanisms, necessitating targeted prevention.


Lindsay Kroener, MD

Latest:

Nurses Can Lead Conversations on Fertility Preservation

As prognoses continue to improve, concerns about treatment-associated fertility risks are becoming more prevalent and are often a topic of discussion between patients and their nurses or nurse practitioners.


Emily S. Weg, MD

Latest:

Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging

Experts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.